Literature DB >> 12192206

Mirtazapine-induced hepatotoxicity.

Chee-Kin Hui1, Man-Fung Yuen, Wai-Man Wong, Shiu-Kum Lam, Ching-Lung Lai.   

Abstract

We report two cases of hepatotoxicity induced by mirtazapine. Two women treated for depression with mirtazapine developed severe hepatotoxicity because of the drug. In the first case, mirtazapine was prescribed for 3 years and the patient developed derangement in liver function with prolonged jaundice, which improved after the withdrawal of mirtazapine. The use of mirtazapine in the second case was associated with prolonged jaundice, which only recovered 3 months after the withdrawal of mirtazapine. The cause of mirtazapine-induced liver toxicity was unknown, and to our knowledge, these are the first reported cases of mirtazapine-induced prolonged jaundice.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12192206     DOI: 10.1097/00004836-200209000-00014

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  7 in total

Review 1.  Pharmacokinetic changes of psychotropic drugs in patients with liver disease: implications for dose adaptation.

Authors:  Chantal Schlatter; Sabin S Egger; Lydia Tchambaz; Stephan Krähenbühl
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

2.  Acute hepatitis after starting pinaverium bromide in a patient taking mirtazapine.

Authors:  Sandeep Tak; Shubhanjali Tak
Journal:  BMJ Case Rep       Date:  2014-07-11

Review 3.  A consensus statement for safety monitoring guidelines of treatments for major depressive disorder.

Authors:  Seetal Dodd; Gin S Malhi; John Tiller; Isaac Schweitzer; Ian Hickie; Jon Paul Khoo; Darryl L Bassett; Bill Lyndon; Philip B Mitchell; Gordon Parker; Paul B Fitzgerald; Marc Udina; Ajeet Singh; Steven Moylan; Francesco Giorlando; Carolyn Doughty; Christopher G Davey; Michael Theodoros; Michael Berk
Journal:  Aust N Z J Psychiatry       Date:  2011-09       Impact factor: 5.744

4.  Hypertensive urgency after administration of a single low dose of mirtazapine-a case report.

Authors:  Jiana Shi; Xiaojun Wang; Yin Ying; Lin Xu; Danyan Zhu
Journal:  Iran J Public Health       Date:  2015-02       Impact factor: 1.429

5.  Drug-Induced Liver Injury during Antidepressant Treatment: Results of AMSP, a Drug Surveillance Program.

Authors:  Michaela-Elena Friedrich; Elena Akimova; Wolfgang Huf; Anastasios Konstantinidis; Konstantinos Papageorgiou; Dietmar Winkler; Sermin Toto; Waldemar Greil; Renate Grohmann; Siegfried Kasper
Journal:  Int J Neuropsychopharmacol       Date:  2016-04-20       Impact factor: 5.176

Review 6.  Psychotropic drugs and liver disease: A critical review of pharmacokinetics and liver toxicity.

Authors:  Diogo Telles-Correia; António Barbosa; Helena Cortez-Pinto; Carlos Campos; Nuno B F Rocha; Sérgio Machado
Journal:  World J Gastrointest Pharmacol Ther       Date:  2017-02-06

7.  Antidepressants and Hepatotoxicity: A Cohort Study among 5 Million Individuals Registered in the French National Health Insurance Database.

Authors:  Sophie Billioti de Gage; Cédric Collin; Thien Le-Tri; Antoine Pariente; Bernard Bégaud; Hélène Verdoux; Rosemary Dray-Spira; Mahmoud Zureik
Journal:  CNS Drugs       Date:  2018-07       Impact factor: 5.749

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.